Post Traumatic Stress Disorder
Conditions
Keywords
PTSD, SEE FAR CBT, Intervention
Brief summary
This single-arm clinical intervention study evaluates a 12-session SEE FAR CBT intervention for adults aged 18 years and older with posttraumatic stress disorder (PTSD). SEE FAR CBT is a trauma-focused cognitive-behavioral treatment approach. Participants will complete self-report psychological questionnaires at three time points: baseline, after completion of the intervention, and at a 3-month follow-up. The study aims to examine changes in PTSD symptoms and related psychological outcomes over the course of treatment and follow-up.
Interventions
BEHAVIORALSEE FAR CBT
SEE FAR CBT is a trauma-focused cognitive-behavioral treatment approach. Participants will receive 12 therapeutic sessions delivered approximately once weekly as a structured psychological intervention for PTSD.
Sponsors
Community Stress Prevention Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
All participants will be assigned to a single group and will receive the 12-session SEE FAR CBT intervention. There is no control or comparison group.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Participants must meet all of the following criteria: * Age 18 years or older * PTSD symptoms, defined as a PCL-5 score of 30 or above * Able to provide informed consent * Willing and able to participate in 12 weekly individual therapy sessions and complete study questionnaires at baseline, post-intervention, and 3-month follow-up
Exclusion criteria
Participants will be excluded if they meet any of the following criteria: * Pregnancy at the time of enrollment, due to the potential influence of pregnancy and childbirth during the treatment or follow-up period on psychological outcomes. * Currently receiving psychotherapy of any type that began less than 3 months prior to enrolment. * Initiation of psychiatric medication less than 3 months prior to enrolment.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in PTSD symptoms | Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention | PTSD Checklist for DSM-5 (PCL-5). PTSD symptoms will be assessed using the PCL-5. Total scores range from 0 to 80, with higher scores indicating greater PTSD symptom severity. Change in PCL-5 total score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up. |
| Change in anxiety symptoms | Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention | Generalized Anxiety Disorder-7 (GAD-7). Anxiety symptoms will be assessed using the GAD-7. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity. Change in GAD-7 total score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in depressive symptoms | Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention | Patient Health Questionnaire-9 (PHQ-9). Depressive symptoms will be assessed using the PHQ-9. Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity. Change in PHQ-9 total score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up. |
| Change in perceived stress | Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention | Perceived Stress Scale (PSS). Perceived stress will be assessed using the PSS. Total scores range from 0 to 40, with higher scores indicating greater perceived stress. Change in PSS total score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up. |
| Change in resilience | Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention | Connor-Davidson Resilience Scale (CD-RISC-10). Resilience will be assessed using the CD-RISC. Total scores range from 0 to 40, with higher scores indicating greater resilience. Change in CD-RISC total score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up. |
| Change in somatic symptoms | Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention | Patient Health Questionnaire-15 (PHQ-15). Somatic symptoms will be assessed using the PHQ-15. Total scores range from 0 to 30, with higher scores indicating greater somatic symptom severity. Change in PHQ-15 total score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up. |
| Change in trauma-related use of imagination and coping | Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention | Fantastic Reality Ability Measurement (FRAME). Trauma-related use of imagination and coping will be assessed using the FRAME questionnaire. The FRAME is a 21-item measure of fantastic reality ability, defined as the capacity to use imagination in response to stress or trauma. Items are rated on a 1-7 Likert scale, and mean scores range from 1 to 7, with higher scores indicating greater fantastic reality ability. Change in FRAME score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up. |
Countries
Israel
Contacts
CONTACTMeital Mashash, PhD
CONTACTSivan Raz, PhD
PRINCIPAL_INVESTIGATORMeital Mashash, PhD
Community Stress Prevention Center
PRINCIPAL_INVESTIGATORSivan Raz, PhD
Tel Hai College
Outcome results
None listed